80
Participants
Start Date
November 30, 1999
Study Completion Date
April 30, 2001
Abacavir sulfate
Beth Israel Med Ctr, New York
Bellevue Hosp / New York Univ Med Ctr, New York
Aaron Diamond AIDS Rsch Ctr / Rockefeller Univ, New York
Columbia Presbyterian Med Ctr, New York
SUNY / Erie County Med Ctr at Buffalo, Buffalo
Univ of Rochester Medical Center, Rochester
Philadelphia Veterans Administration Med Ctr, Philadelphia
Univ of Pennsylvania at Philadelphia, Philadelphia
Johns Hopkins Hosp, Baltimore
Duke Univ Med Ctr, Durham
Julio Arroyo, West Columbia
Emory Univ, Atlanta
Vanderbilt Univ Med Ctr, Nashville
Northwestern Univ Med School, Chicago
Cook County Hosp, Chicago
St Louis Regional Hosp / St Louis Regional Med Ctr, St Louis
Univ of Texas, Southwestern Med Ctr of Dallas, Dallas
Univ of Colorado Health Sciences Ctr, Denver
UCLA CARE Ctr, Los Angeles
Harbor UCLA Med Ctr, Torrance
Willow Clinic, Menlo Park
Univ of Washington, Seattle
State of MD Div of Corrections / Johns Hopkins Univ Hosp, Baltimore
Univ of North Carolina, Chapel Hill
Univ of Miami School of Medicine, Miami
Univ of Cincinnati, Cincinnati
San Mateo AIDS Program / Stanford Univ, Stanford
Stanford Univ Med Ctr, Stanford
Santa Clara Valley Med Ctr / AIDS Community Rsch Consortium, San Jose
Univ of Puerto Rico, San Juan
National Institute of Allergy and Infectious Diseases (NIAID)
NIH